Elevance Health, Inc. (ELV) Stock Forecast Oct. 13, 2026
Analysis updated on Oct. 13, 2026 (UTC) · Total · absolute moveSwitch to Alpha · NYSE
Elevance Health, Inc. (ELV) stock forecast summary
On Oct. 13, 2026, ELV is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 4009 stocks scored that day.
Elevance Health, Inc. is a large-cap company with a market capitalization of $92.23B. It ranks number 2 by market capitalization among the 10 Hospital & Medical Service Plans issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for ELV is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +4.5%, buy ≥ +3.4%, sell < +2.1%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, ELV included.
Follow ELV freeELV price chart and AI forecast
How ELV ranks among 4009 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Elevance Health, Inc. (ELV) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Hospital & Medical Service Plans peers listed below that report each metric.
Valuation & Market
| Metric | ELV | Rank |
|---|---|---|
| Market Cap | $92.23B | 2/10 |
| P/E Ratio | 18.58x | 4/5 |
| P/B Ratio | 2.05x | 8/10 |
| Dividend Yield | 1.63% | – |
| EPS | $22.59 | – |
| Book Value/Share | $206.96 | – |
| Revenue/Share | $927.35 | – |
| FCF/Share | $29.00 | – |
Profitability & Margins
| Metric | ELV | Rank |
|---|---|---|
| ROE | 11.1% | 4/8 |
| ROA | 3.9% | 4/8 |
| ROIC | 6.6% | 6/10 |
| Gross Margin | 89.1% | 2/6 |
| Operating Margin | 2.7% | 4/10 |
| Net Margin | 2.5% | 3/8 |
| EBT Margin | 2.9% | 4/10 |
| Tax Rate | 15.6% | – |
Financial Health
| Metric | ELV | Rank |
|---|---|---|
| Current Ratio | 1.52x | 5/10 |
| D/E Ratio | 1.81x | 8/10 |
| Financial Leverage | 2.82x | 8/10 |
| Interest Coverage | 4.7x | 7/9 |
| Working Capital | $22.93B | 1/10 |
Cash Flow
| Metric | ELV | Rank |
|---|---|---|
| Operating Cash Flow | $7.46B | 4/10 |
| Free Cash Flow | $6.29B | 3/9 |
| Capital Spending | -$1.18B | 8/9 |
| OCF Growth YoY | 15.7% | 6/9 |
| FCF Growth YoY | 17.8% | 5/8 |
| FCF/Sales | 3.1% | 6/9 |
| CapEx/Sales | 0.6% | 4/9 |
Operational Efficiency
| Metric | ELV | Rank |
|---|---|---|
| Asset Turnover | 1.59x | 8/10 |
| Fixed Assets Turnover | 43.3x | 8/10 |
Income Statement
| Metric | ELV | Rank |
|---|---|---|
| Total Revenue | $201.11B | 4/10 |
| Operating Income | $5.45B | 3/10 |
| Net Income | $4.96B | 3/8 |
| SG&A Expense | $22.56B | 2/8 |
| Cost of Goods Sold | $21.86B | 4/6 |
Dividend & Shareholder Information
| Metric | ELV | Rank |
|---|---|---|
| Dividends Per Share | $6.95 | – |
| Payout Ratio | 30.8% | – |
| Shares Outstanding | 217M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $67.18B | 53.1% of assets |
| Cash & Short-term Investments | $10.23B | 8.1% of assets |
| Total Liabilities | $81.42B | 64.4% of assets |
ELV quarterly financials and insider trading
Elevance Health, Inc. (ELV) industry peers
Companies classified under the same SEC industry code as Elevance Health, Inc. (Hospital & Medical Service Plans): 10 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| ELV Elevance Health, Inc. | ▶ | $92.23B |
| UNH Unitedhealth Group Inc | ▶ | $339.08B |
| CI Cigna Group | ▶ | $74.66B |
| HUM Humana Inc | ▲ | $50.47B |
| CNC Centene Corp | ▲ | $34.02B |
| MOH Molina Healthcare, Inc. | ▶ | $10.94B |
| OSCR Oscar Health, Inc. | ▲ | $10.43B |
| CLOV Clover Health Investments, Corp. /De | ▲ | $2.55B |
| ALHC Alignment Healthcare, Inc. | ▲ | $1.72B |
| TRUP Trupanion, Inc. | ▼ | $1.17B |
Where ELV sits on the market map
Elevance Health, Inc. (ELV) stock news
Loading...
Elevance Health, Inc. (ELV) stock forecast FAQ
What is the Elevance Health, Inc. (ELV) stock forecast?
On Oct. 13, 2026, ELV is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 4009 stocks scored that day.
How accurate are Elevance Health, Inc. stock predictions?
A per-ticker accuracy statistic for ELV is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Elevance Health, Inc. forecasts updated?
Elevance Health, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
Which companies are Elevance Health, Inc.'s industry peers?
10 issuers in our coverage, ELV included, share the SEC industry code Hospital & Medical Service Plans. The largest are: Unitedhealth Group Inc (UNH), Cigna Group (CI), Humana Inc (HUM), Centene Corp (CNC), Molina Healthcare, Inc. (MOH), Oscar Health, Inc. (OSCR).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.